Zobrazeno 1 - 10
of 165
pro vyhledávání: '"John A"'
Autor:
Jayaram N; Children's Mercy Hospitals and Clinics, Kansas City, MO. Electronic address: njayaram@cmh.edu., Spertus JA; Saint Luke's Mid America Heart Institute/UMKC, Kansas City, MO. Electronic address: spertusj@umkc.edu., O'Byrne ML; Children's National Medical Center, Washington, DC; George Washington University School of Medicine, Washington, DC. Electronic address: MLOBYRNE@childrensnational.org., Chan PS; Saint Luke's Mid America Heart Institute/UMKC, Kansas City, MO. Electronic address: paulchan.mahi@gmail.com., Kennedy KF; Saint Luke's Mid America Heart Institute/UMKC, Kansas City, MO. Electronic address: kfkennedy@saint-lukes.org., Bergersen L; Boston Children's Hospital, Boston, MA. Electronic address: Lisa.Bergersen@CARDIO.CHBOSTON.ORG., Glatz AC; The Children's Hospital of Philadelphia, Philadelphia, PA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. Electronic address: GLATZ@email.chop.edu.
Publikováno v:
American heart journal [Am Heart J] 2017 Jan; Vol. 183, pp. 118-128. Date of Electronic Publication: 2016 Oct 08.
Autor:
Maron DJ; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. david.maron@vanderbilt.edu, Stone GW, Berman DS, Mancini GB, Scott TA, Byrne DW, Harrell FE Jr, Shaw LJ, Hachamovitch R, Boden WE, Weintraub WS, Spertus JA
Publikováno v:
American heart journal [Am Heart J] 2011 Dec; Vol. 162 (6), pp. 1034-1043.e13.
Autor:
Leslee J. Shaw, William E. Boden, David J. Maron, Sripal Bangalore, Judith S. Hochman, Karen P. Alexander, Daniel B. Mark, Yves Rosenberg, T. Bruce Ferguson, Jeffrey S. Berger, David O. Williams, Robert A. Harrington, Harmony R. Reynolds, John A. Spertus, Gregg W. Stone, Sean M. O'Brien
Publikováno v:
American Heart Journal. 201:124-135
BACKGROUND: Prior trials comparing a strategy of optimal medical therapy with or without revascularization have not shown that revascularization reduces cardiovascular events in patients with stable ischemic heart disease (SIHD). However, those trial
Autor:
Daniel L. McGee, James Campbell, Ashley Meredith, Mathew Parkin, Vishal Dahya, Patty Knap, John Katopodis, William C. Dixon, Thomas Noel, Wayne Batchelor
Publikováno v:
American Heart Journal. 198:75-83
Background There exist limited data on the relative degree of acute injury and late healing of the radial artery after transradial artery (TRA) percutaneous coronary intervention (PCI) with a 7F sheathless guide catheter compared with a 6F sheath/gui
Autor:
Lakkireddy, Dhanunjaya, Windecker, Stephan, Thaler, David, Søndergaard, Lars, Carroll, John, Gold, Michael R., Guo, Hongfei, Brunner, Kyle J., Hermiller, James B., Diener, Hans Christoph, Schmidt, Boris, MacDonald, Lee, Mansour, Moussa, Maini, Brijeshwar, Levine, Joseph, Sondergaard, Lars
Publikováno v:
American heart journal. 211
The Amulet IDE Trial is an ongoing, prospective, randomized, multi-national trial, designed to evaluate the safety and effectiveness of the AMPLATZER Amulet Left Atrial Appendage Occluder for stroke prevention in comparison to the WATCHMAN Left Atria
Autor:
Thomas Pfister, Emmanuel Bergot, John Granton, David Langleben, Jean-Christophe Lemarié, Anco Boonstra, Olivier Sitbon, Gérald Simonneau, Marion Delcroix, Pilar Escribano Subías, Nazzareno Galiè
Publikováno v:
Sitbon, O, Delcroix, M, Bergot, E, Boonstra, A, Granton, J, Langleben, D, Subias, P E, Galie, N, Pfister, T, Lemarie, J C & Simonneau, G 2014, ' EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension ', The American Heart Journal, vol. 167, no. 2, pp. 210-217 . https://doi.org/10.1016/j.ahj.2013.08.007
The American Heart Journal, 167(2), 210-217
The American Heart Journal, 167(2), 210-217
Background Continuous infusion of epoprostenol is the treatment of choice in patients with pulmonary arterial hypertension in functional classes III to IV. However, this treatment's limitations include instability at room temperature. A new epoproste
Autor:
Akshay Bagai, Asim N. Cheema, Michael J.B. Kutryk, Jo-Ann Christie, John J. Graham, Jonathan Lu, Chris Buller, Neil Fam
Publikováno v:
American Heart Journal. 173:126-133
Background The implementation of regional primary percutaneous coronary intervention (PCI) programs has been critical in achieving timely intervention in patients with ST-segment elevation myocardial infarction (STEMI). However, 1 consequence has bee
Autor:
Jean Champagne, George A. Wells, Marc W. Deyell, Atul Verma, Jason G. Andrade, Alan C. Skanes, Vidal Essebag, Early-Af Study Investigators, John L. Sapp, Patricia Theoret-Patrick, Sandra Lauck, Carlos A. Morillo
Publikováno v:
American heart journal. 206
Background The ideal management of patients with newly diagnosed symptomatic atrial fibrillation (AF) remains unknown. Current practice guidelines recommend a trial of antiarrhythmic drugs (AAD) prior to considering an invasive ablation procedure. Ho
Autor:
Connie N. Hess, Mitchell W. Krucoff, Roxana Mehran, Sunil V. Rao, Kevin J. Anstrom, John C. Messenger, Ian C. Gilchrist, Alice K. Jacobs, Robert A. Harrington, W. Britt Barham, Shubin Sheng, Daniel B. Mark
Publikováno v:
American Heart Journal. 170:371-379
Background In the SAFE-PCI for Women trial, patient preference for radial access for future procedures was greater than for femoral access. We sought to assess whether radial or femoral access impacts formal measures of quality-of-life (QOL) among wo
Autor:
Fang Shu Ou, Paul A. Hudson, P. Michael Ho, John C. Messenger, John S. Rumsfeld, Michael S. Kim, Tracy Y. Wang, Andrew J. Klein, Frederick A. Masoudi
Publikováno v:
American Heart Journal. 160:951-957
Background The American College of Cardiology/American Health Association guidelines recommend both an early invasive strategy and administration of antiplatelet/anticoagulant therapy for high-risk patients in the absence of contraindications. Little